Beilin Le
乐贝林
Beilin Le (乐贝林) is a Managing Director at Gaorong Ventures covering healthcare — he first appeared as Executive Director hosting a biotech panel in 2022 and by 2024 was quoted as MD . In Gaorong's own words through him, the fund's healthcare thesis is backing "companies with global innovation capability and competitiveness" and walking with them "onto the international stage" . His visible portfolio touchpoints are consistent with that global-leaning line: ProfoundBio's $1.8B acquisition by Genmab , Saint Bella's Hong Kong IPO (Gaorong an early investor; Le praised the company's "fast and slow" positioning) , and Cornerstone Robotics, where he recalled meeting founders Sam, Jerry and Alexis back in 2018 — a company that received a ~$700M strategic investment from Medtronic in 2026 . He was also named to a Top 20 healthcare investor list in 2025 . Elsewhere's corpus has no independent profile of him beyond Gaorong's own coverage, so details like background and career history aren't documented here.
AI-generated — may contain errors, please verify.
Coverage
Cornerstone Robotics Receives Around $700 Million Strategic Investment From Medtronic to Jointly Expand Surgical Robot Global Market
Making Robot-Assisted Surgery More Accessible Worldwide
Rongbao | Multiple autonomous driving, nuclear fusion, gaming, and innovative drug companies raise hundreds of millions of RMB in funding
From commercial deployment to world-first breakthroughs, innovation never stands still.
Warm congratulations to Saint Bella on its successful Hong Kong IPO. Gaorong Ventures was an early investor and has been a long-term partner throughout.
Hong Kong's stock market welcomes the "first share of family quality care."
Congratulations to Mirxes on its successful listing on the Hong Kong Stock Exchange's Main Board — Gaorong Ventures was its earliest institutional investor.
A leading provider of molecular cancer screening products and services.
Gaorong Ventures in Conversation with Hejeya and Qitan Tech: How Innovative Medical Devices "Cross the Razor's Edge"
"When you meet a mountain, you cut a path through it; when you meet a river, you build a bridge across it."
Genmab Acquires ProfoundBio for $1.8 Billion | Gaorong Ventures News
Accelerate the development and unlock the full potential of ADC therapies.
From Big Pharma to Biotech: Four Industry Leaders on How Innovative Drugs Can Balance Speed and Quality | Ronghui
Speed matters, but getting it right matters more.
Robotics, SaaS, and innovative drug sectors close new funding rounds; chips and medical devices unveil major new products | Rongbao · August
Differentiated innovation and global opportunities.
